Royal Bank Of Canada Neovasc Inc Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$15.81 - $29.88 $3,019 - $5,707	191 Added 12.01%	1,782 $51,000
Q4 2022 Feb 14, 2023	BUY	$6.5 - $16.05 $2,899 - $7,158	446 Added 38.95%	1,591 $25,000
Q3 2022 Nov 14, 2022	SELL	$5.95 - $7.93 $7,253 - $9,666	-1,219 Reduced 51.57%	1,145 $8,000
Q2 2022 Aug 15, 2022	BUY	$4.9 - $10.75 $11,583 - $25,413	2,364 New	2,364 $14,000

Ticker NVCN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,743,140
Description
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.